Hironobu Mitani

Dipeptidyl Peptidase IV Inhibition Improves Impaired Glucose Tolerance in High-Fat Diet-Fed Rats: Study Using a Fischer 344 Rat Substrain Deficient in Its Enzyme Activity

Hironobu Mitani, Misato Takimoto, Thomas E. Hughes et al. · The Japanese Journal of Pharmacology · 2002 · 63 citations · Full text

Inhibitory effects of fluvastatin, a new HMG‐CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol‐fed rabbits

Hironobu Mitani, Tsutomu Bandoh, Junji Ishikawa et al. · British Journal of Pharmacology · 1996 · 53 citations · Full text

Hypertension, Vascular Ace, Cardiovascular Pharmacology +19

HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent “direct” effects on atherosclerotic vessels in high cholesterol diet-fed rabbits

Hironobu Mitani · Pharmacological Research · 2003 · 42 citations

Cardiovascular Disease, Medicine, Physiology +8

Fluvastatin Suppresses Atherosclerotic Progression, Mediated Through Its Inhibitory Effect on Endothelial Dysfunction, Lipid Peroxidation, and Macrophage Deposition

Tsutomu Bandoh, Hironobu Mitani, Mari Niihashi et al. · Journal of Cardiovascular Pharmacology · 2000 · 39 citations

Lipid Peroxidation, Immunology, Hyperlipidemia +16

Inhibitory effect of fluvastatin at doses insufficient to lower serum lipids on the catheter-induced thickening of intima in rabbit femoral artery

Tsutomu Bandoh, Hironobu Mitani, Mari Niihashi et al. · European Journal of Pharmacology · 1996 · 37 citations

Thrombosis, Vascular Disease, Cardiovascular Disease +10